The Journal of Clinical Endocrinology & Metabolism · 2013 · 15 citations · 6 references
MedicineGynecologyObstetricsArtificial InseminationReproductive EndocrinologyReproductive MedicineAdenomyosisFemale InfertilityFetal ImagingInfertility EvaluationPregnancyArtificial Insemination By HusbandArtificial Vaginal InseminationBrow PresentationInfertility WorkupThyroid Function EvaluationThyroid Function MonitoringThyroid Function TestingThyroid Function Tests
A40-year-old woman was referred to Chiba University Hospital (Chiba, Japan) at 34 weeks gestation because of an abnormal mass observed in the neck of her fetus, which was noticed at the scheduled check-up at 34 weeks. The patient had been infertile for 3 years after two spontaneous abortions. Infertility workup revealed adenomyosis (47 45 mm) of the uterus; the patient was otherwise normal. The patient’s TSH level (0.66 IU/mL), measured at 8 weeks before conception, was within normal limits. She had undergone hysterosalpingography (HSG) with 10 mL of ethiodized oil (Lipiodol; Guerbet) on day 8 of a menstrual cycle, followed by artificial insemination using her husband’s sperm, resulting in successful conception on the HSG treatment cycle. Ultrasonography demonstrated a 55 36 32-mm hypervascular mass at the anterior part of the neck of the fetus (Figure 1, A and B). Three-dimensional imaging revealed a large goiter, possibly preventing neck flexion (Figure 1C). Persistent brow presentation indicated cesarean section, and the patient delivered a 2844-g baby boy at 37 weeks and 3 days of gestation, with an Apgar score of 8 at 1 minute after delivery. The baby’s goiter resolved spontaneously and became impalpable at postnatal week 4. Abnormal thyroid function of the baby (TSH, free T4, and free T3 were 88.1 U/mL [reference range, 4.5–14.5], 0.60 ng/dL [1.05–1.61 ng/dL], and 2.33 pg/mL [1.43–2.19 pg/ mL], respectively, in cord blood; and 190.6 U/mL [8.09– 38.9 U/mL], 0.66 ng/dL [1.37–3.65 ng/dL], and 2.77 pg/mL [1.59–8.11 pg/ml], respectively, in peripheral blood obtained shortly after birth) resolved without treatment by postnatal day 7 (TSH, 8.45 U/mL [0.51–4.57 U/mL]; free T4, 1.35 ng/dL [0.96–4.08 ng/dL]; and free T3, 3.57 pg/mL [2.65–4.57 pg/mL]). Iodine concentration in neonatal urine determined on postnatal day 7 was 980 g/L, which was higher than the upper limit (300 g/L) for preschool infancy and the lower limit (185 g/L) for an iodine-exposed newborn (1). Thyroid function tests of the neonate conducted thereafter have been normal, and no palpable goiter has recurred until 2 years of age. Maternal thyroid function (TSH, 1.2 U/mL; free T4, 0.92 ng/dL; and free T3, 2.56 pg/mL) was normal, and thyroid-related autoantibodies were not detectable at 34 weeks gestation.
6
Paula R. Trumbo, Allison A. Yates, Sandra A. Schlicker et al. · Journal of the American Dietetic Association · 2001 · 4.9K citations
Congenital Hypothyroidism Caused by Excess Prenatal Maternal Iodine Ingestion
Kara J. Connelly, Bruce A. Boston, Elizabeth N. Pearce et al. · The Journal of Pediatrics · 2012 · 136 citations · Full text
Medicine, Endocrinology, Obstetrics +14